- Chemours (NYSE:CC): Q1 Non-GAAP EPS of $0.71 beats by $0.08; GAAP EPS of $0.57.
- Revenue of $1.44B (+10.8% Y/Y) beats by $40M.
-
2021 Revised Outlook
- Adjusted EBITDA* between $1.10 and $1.25 billion, up $100 million at the midpoint vs. prior outlook
- Adjusted EPS* between ~$2.84 and $3.56 vs. prior expectation of ~$2.40 and $3.12 vs. $2.75 consensus.
- Free Cash Flow* now expected to be greater than $450 million, up $100 million vs. prior outlook
- Press Release
Chemours EPS beats by $0.08, beats on revenue
Recommended For You
More Trending News
About CC Stock
Related Stocks
Symbol | Last Price | % Chg |
---|---|---|
CC | - | - |
The Chemours Company |